SIGA Technologies, Inc.
NASDAQ:SIGA
7.21 (USD) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SIGA Technologies, Inc. |
Symbool | SIGA |
Munteenheid | USD |
Prijs | 7.21 |
Beurswaarde | 514,572,653 |
Dividendpercentage | 7.64% |
52-weken bereik | 4.26 - 12.83 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Phillip Louis Gomez III, M.D., Ph.D. |
Website | https://www.siga.com |
An error occurred while fetching data.
Over SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)